Browse the full directors' dealings record of ULURU Inc., a listed issuer based in United States. Shares trade on US US, under the oversight of SEC (Form 4). Market capitalisation: €10.8bn. The latest transaction was filed on 2 February 2016 (Attribution). Among the most active insiders: IPMD GmbH. Every trade is accessible without an account.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
ULURU Inc. is a company focused on developing medical products, particularly treatments for wounds. It is listed on NASDAQ under the ticker ULUR.